diazan

07/01/1981 - "Diazane and NMU hold promise for clinical trials in human breast cancer."
07/01/1981 - "A study was made of the effect of nitrosomethylurea (NMU), thiophosphamide and diazane on proliferative activity of human breast cancer cells cultured in diffusion chambers in vivo. "

01/01/1985 - "L 1210 leukemia strain resistant to diazan (L 1210/D1) was studied for its drug sensitivity in comparison with the parent strain. "
01/01/1980 - "[Diazane resistance of leukemia L1210 strain: obtaining and kinetic characteristics of growth]."
01/01/1976 - "[Influence of diazan on the mitotic cycle of leukemia L1210 cells]."
01/01/1985 - "[Changes in the chemotherapy sensitivity of leukemia L1210 cells during the development of diazan resistance]."
01/01/1984 - "The dose and schedule dependent resistance occurred at the 17th (L1210/D1) and 27th (L1210/D2) generations during leukemia L1210 transplantation by the cells treated with suboptimal diazane doses. "

03/01/1981 - "The effect of the antitumorigenic agent diazane (1,2-bis-diazoacetylethane) in the cells of 30 human tumors cultured in vivo in diffusion chambers, implanted intraperitoneally into mice. "
03/01/1981 - "The effect of diazane on the proliferation of human tumor cells."
03/01/1981 - "[Effect of diazan on proliferation of human tumor cells]."
11/01/1976 - "Diazane markedly inhibits the growth of certain experimental tumors and increases the mean survival time of animals with leukemias, even after a single injection. "
04/01/1979 - "Antitumor efficiency of combined therapy of experimental tumors with diazan and antibiotics was studied. "

01/01/1984 - "With growth of the resistance to diazane the selection of modal cell class with 39 chromosomes took place while in the parent leukemia line the modal cell class consists of the cells with 40 chromosomes. "
01/01/1980 - "[Effect of diazane on the mitotic cycle of transplantable leukemia LA in mice]."
11/01/1976 - "Diazane markedly inhibits the growth of certain experimental tumors and increases the mean survival time of animals with leukemias, even after a single injection. "
01/01/1979 - "The effectiveness of the combined therapy of leukemia P-388 with cyclophosphane and diazane was studied. "

03/18/2008 - "Though all substances have the potential to form self-assembled monolayers (SAMs), only two of them, disulfanediyl-bis(ethane-2,1-diyl) bis(4-styrylbenzoate) (1) and 4-[(2,4-dioxo-3-pentylidene)diazane-2,2,1-triyl]phenyl thioctate (4), yield the expected structure, the latter one showing the possibility to incorporate diarylketohydrazone moieties into SAMs. "